Sven Ante Lundberg insider trades

Open-market stock purchases and sales by Sven Ante Lundberg, Unknown at Q32 Bio Inc, from SEC Form 4 filings since Oct 24, 2016.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +287%.

Recent trades

DateStockTradeValue
Jun 12, 2026QTTB Q32 Bio IncBought (not open market)—
Jan 15, 2026QTTB Q32 Bio IncBought (not open market)$56K
Dec 12, 2025MRUS Merus NVSold (not open market)$2.9M
Dec 12, 2025MRUS Merus NVSold (not open market)$1.6M
Dec 12, 2025MRUS Merus NVSold (not open market)$892K
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)—
Dec 12, 2025MRUS Merus NVSold (not open market)$892K
Dec 12, 2025MRUS Merus NVSold (not open market)—
Nov 25, 2025MRUS Merus NVBought (not open market)—
Nov 25, 2025MRUS Merus NVSold (not open market)—
Nov 25, 2025MRUS Merus NVSold (not open market)—
Nov 25, 2025MRUS Merus NVSold (not open market)—
Nov 25, 2025MRUS Merus NVSold (not open market)—
Nov 25, 2025MRUS Merus NVSold (not open market)—
Nov 25, 2025MRUS Merus NVBought (not open market)—
Nov 25, 2025MRUS Merus NVBought (not open market)—
Oct 23, 2025QTTB Q32 Bio IncBought (not open market)—

Companies traded

  • QTTB Q32 Bio Inc: other filings, last Jun 12, 2026
  • MRUS Merus NV: 4 buys, last Dec 12, 2025
  • VOR Vor Biopharma Inc: other filings, last May 22, 2025
  • CRSP CRISPR Therapeutics AG: 1 buy, last Oct 24, 2016

Get free alerts when Sven Ante Lundberg files a new trade →